Latest Breaking News On - Medical research acquisition - Page 1 : comparemela.com

3M wins $34 2M contract to develop wound care solutions

3M Health Care announced that it received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity.

San antonioUnited statesUniversity of texasUniversity of minnesotaRaymond chiuSolutions divisionNaval medical research unitHealth careUs army medical research acquisition activitySan antonio ut healthM health careUniversity of texas health science centerUniversity of minnesota medical schoolMedical solutions divisionMedical research acquisitionMinnesota medical school

Research reveals vaccine rapidly protects against lethal Lassa fever

Research reveals vaccine rapidly protects against lethal Lassa fever
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesTexas medical centerUniversity of texasKarlaa fentonNatalies dobiasAbhishekn prasadCourtney woolseyJoanb geisbertRobertw crossThomasw geisbertRobert crossViktoriya borisevichTom geisbertHuman servicesNational institutes of healthWorld health organization

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

Pimera Therapeutics Awarded Grant by US Department of Defense to Evaluate PMR-116, a Novel Inhibitor of RNA Polymerase I (Pol I) Transcription, in Patients with Prostate Cancer

/PRNewswire/ Pimera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing breakthrough medicines for cancer and other diseases.

Mustapha haddachAmy conradLuc furicRoss hannanAustralian national universityDepartment of defenseDean research biomedicalCancer researchProstate cancer research programDepartment of cancer biologyPimera therapeutics incPimera therapeuticsTranslational prostate cancer researchPeter maccallum cancer centreProfessor ross hannanCentenary chair

Draper Develops Artificial Lung Technology with $4 9M U S Army Grant, Earns ASAIO Award

Draper Develops Artificial Lung Technology with $4 9M U S Army Grant, Earns ASAIO Award
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJeff borensteinJoe santosUs army medical research acquisition activityPeer reviewed medical research programUs armyAmerican society for artificial internal organsAmerican societyArtificial internal organsTop pulmonary abstractMedical research acquisition activityMedical research acquisitionஒன்றுபட்டது கிஂக்டம்ஒன்றுபட்டது மாநிலங்களில்ஓஹோ சாண்டோஸ்